SEC Form 4Coverage since May 26, 2026
$BDX insider trading
Over the last 12 months, Becton Dickinson insiders reported no purchases and 7 sales totaling $3.3M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $3.3M 7 events
- Events · 12m
- 7 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $BDX · 12Mvia TradingView
Top insiders · 12m
Feld MichaelEVP, Chief Revenue Officer3× · $34K
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm2× · $327K
Polen Thomas E JrChairman, CEO and President2× · $3.0M
All insider trades
7 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Feld MichaelEVP, Chief Revenue Officer · O | ▼ Sale | 75 | $157.13 | $12K | -0.4% | plan |
| Jun 26, 2026 | Feld MichaelEVP, Chief Revenue Officer · O | ▼ Sale | 75 | $152.8 | $11K | -0.4% | plan |
| Jun 24, 2026 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm · O | ▼ Sale | 1,100 | $145.66 | $160K | -7.7% | plan |
| Jun 10, 2026 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm · O | ▼ Sale | 1,100 | $151.48 | $167K | -7.2% | plan |
| Jun 1, 2026 | Polen Thomas E JrChairman, CEO and President · O·D | ▼ Sale | 2,764 | $146.35 | $405K | -2.4% | plan |
| Jun 1, 2026 | Polen Thomas E JrChairman, CEO and President · O·D | ▽ Sale to issuer | 17,445 | $146.15 | $2.5M | -13.9% | plan |
| May 26, 2026 | Feld MichaelEVP, Chief Revenue Officer · O | ▼ Sale | 75 | $147.35 | $11K | -0.4% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $BDX feed.